SEC investigating corruption allegations against Chinese biopharma company

The US Securities and Exchange Commission has issued Sinovac Biotech a subpoena requesting information about an internal investigation carried out by the Chinese biopharmaceutical company into bribery allegations.

Get unlimited access to all Global Investigations Review content